Immune challenge induces differential corticosterone and interleukin-6 responsiveness in rats bred for extremes in anxiety-related behavior

Neuroscience

Volumn 151, Issue 4, 2008, Pages 1112-1118

  Salome, N ^a   Tasiemski, A ^a   Dutriez, I ^a   Wigger, A ^b   Landgraf, R ^b   Viltart, O ^a,c  

^a UNIV LILLE   (France)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^c INSTITUT PASTEUR DE LILLE   (France)

Author keywords

HAB rats; HPA axis; immune system; innate anxiety; lipopolysaccharide

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; HORMONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADRENOCORTICOTROPIC HORMONE; ANALYSIS OF VARIANCE; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; BODY WEIGHT; BRAIN; CORTICOSTERONE; COSYNTROPIN; DISEASE MODELS, ANIMAL; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; PROTEIN BINDING; RATS; RECEPTORS, CORTICOTROPIN;

EID: 39149107769     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.12.010     Document Type: Article

References (64)

1. Anisman H., and Merali Z. Cytokines, stress, and depressive illness. Brain Behav Immun 16 (2002) 513-524
2. Anisman H., and Matheson K. Stress, depression, and anhedonia: caveats concerning animal models. Neurosci Biobehav Rev 29 (2005) 525-546
3. Armario A., Hernández J., Bluethmann H., and Hidalgo J. IL-6 deficiency leads to increased emotionality in mice: evidence in transgenic mice carrying a null mutation for IL-6. J Neuroimmunol 92 (1998) 160-169
4. Basterzi A.D., Aydemir C., Kisa C., Aksaray S., Tuzer V., Yazici K., and Goka E. IL-6 levels decrease with SSRI treatment in patients with major depression. Hum Psychopharmacol 20 (2005) 473-476
5. Bethin K.E., Vogt S.K., and Muglia L.J. Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation. Proc Natl Acad Sci U S A 97 (2000) 9317-9322
6. Butterweck V., Prinz S., and Schwaninger M. The role of interleukin-6 in stress-induced hyperthermia and emotional behaviour in mice. Behav Brain Res 144 (2003) 49-56
7. Calapai G., Crupi A., Firenzuoli F., Inferrera G., Squadrito F., Parisi A., De Sarro G., and Caputi A. Related serotonin, norepinephrine and dopamine involvement in the antidepressant action of hypericum perforatum. Pharmacopsychiatry 34 (2001) 45-49
8. Capuron L., and Dantzer R. Cytokines and depression: the need for a new paradigm. Brain Behav Immun 17 (2003) S119-S124
9. Chatelain D., Montel V., Dickes-Coopman A., Chatelain A., and Deloof S. Trophic and steroidogenic effects of water deprivation on the adrenal gland of the adult female rat. Regul Pept 110 (2003) 249-255
10. Chourbaji S., Urani A., Inta I., Sanchis-Segura C., Brandwein C., Zink M., Schwaninger M., and Gass P. IL-6 knockout mice exhibit resistance to stress-induced development of depression-like behaviors. Neurobiol Dis 23 (2006) 587-594
11. Dantzer R., Wollman E.E., and Yirmiya R. Cytokines and depression: an update. Brain Behav Immun 16 (2003) 501-502
12. Finck B.N., and Johnson R.W. Anorexia, weight loss and increased plasma interleukin-6 caused by chronic intracerebroventricular infusion of interleukin-1beta in the rat. Brain Res 761 (1997) 333-337
13. Frank E., Salchner P., Aldag J.M., Salome N., Singewald N., Landgraf R., and Wigger A. Genetic predisposition to anxiety-related behavior determines coping style, neuroendocrine responses, and neuronal activation during social defeat. Behav Neurosci 120 (2006) 60-71
14. Frommberger U.H., Bauer J., Haselbauer P., Fraulin A., Riemann D., and Berger M. Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur Arch Psychiatry Clin Neurosci 247 (1997) 228-233
15. Givalois L., Dornand J., Mekaouche M., Solier M.D., Bristow A.F., Ixart G., Siaud P., Assenmacher I., and Barbanel G. Temporal cascade of plasma level surges in ACTH, corticosterone, and cytokines in endotoxin-challenged rats. Am J Physiol 267 (1994) R164-R170
16. Grippo A.J., Francis J., Beltz T.G., Felder R.B., and Johnson A.K. Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia. Physiol Behav 84 (2005) 697-706
17. Haack M., Hinze-Selch D., Fenzel T., Kraus T., Kuhn M., Schuld A., and Pollmacher T. Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis. Psychiatr Res 33 (1999) 407-418
18. Harkins J.M., Moustaid-Moussa N., Chung Y.J., Penner K.M., Pestka J.J., North C.M., and Claycombe K.J. Expression of interleukin-6 is greater in preadipocytes than in adipocytes of 3T3-L1 cells and C57BL/6J and ob/ob mice. J Nutr 134 (2004) 2673-2677
19. Henniger M.S., Ohl F., Hölter S.M., Weissenbacher P., Toschi N., Lörscher P., Wigger A., Spanagel R., and Landgraf R. Unconditioned anxiety and social behaviour in two rat lines selectively bred for high and low anxiety-related behaviour. Behav Brain Res 111 (2000) 153-163
20. Hogan D., Morrow J.D., Smith E.M., and Opp M.R. Interleukin-6 alters sleep of rats. J Neuroimmunol 137 (2003) 59-66
21. Holmes A.G., Watt M.J., and Febbraio M.A. Suppressing lipolysis increases interleukin-6 at rest and during prolonged moderate-intensity exercise in humans. J Appl Physiol 97 (2004) 689-696
22. Kahl K.G., Kruse N., Rieckmann P., and Schmidt M.H. Cytokine mRNA expression patterns in the disease course of female adolescents with anorexia nervosa. Psychoneuroendocrinology 29 (2004) 13-20
23. Keck M.E., Wigger A., Welt T., Müller M.B., Gesing A., Reul J.M., Holsboer F., Landgraf R., and Neumann I. Vasopressin mediates the response of the combined dexamethasone/CRH test in hyperanxious rats: implications for pathogenesis of affective disorders. Neuropsychopharmacology 26 (2002) 94-105
24. Keck M.E., Sartori S.B., Welt T., Muller M.B., Ohl F., Holsboer F., Landgraf R., and Singewald N. Differences in serotonergic neurotransmission between rats displaying high or low anxiety/depression-like behaviour: effects of chronic paroxetine treatment. J Neurochem 92 (2005) 1170-1179
25. Kubera M., Kenis G., Bosmans E., Zieba A., Dudek D., Nowak G., and Maes M. Plasma levels of interleukin-6, interleukin-10, and interleukin-1 receptor antagonist in depression: comparison between the acute state and after remission. Pol J Pharmacol 52 (2000) 237-241
26. Kubera M., Kenis G., Bosmans E., Kajta M., Basta-Kaim A., Scharpe S., Budziszewska B., and Maes M. Stimulatory effect of antidepressants on the production of IL-6. Int Immunopharmacol 4 (2004) 185-192
27. Lancel M., Müller-Preuss P., Wigger A., Landgraf R., and Holsboer F.J. The CRH1 receptor antagonist R121919 attenuates stress-elicited sleep disturbances in rats, particularly in those with high innate anxiety. Psychiatr Res 36 (2002) 197-208
28. Landgraf R., Wigger A., Holsboer F., and Neumann I.D. Hyper-reactive hypothalamo-pituitary-adrenocortical axis in rats bred for high anxiety-related behaviour. J Neuroendocrinol 11 (1999) 405-407
29. Landgraf R., and Wigger A. Born to be anxious: neuroendocrine and genetic correlates of trait anxiety in HAB rats. Stress 6 (2003) 111-119
30. Landgraf R., Kessler M.S., Bunck M., Murgatroyd C., Spengler D., Zimbelmann M., Nussbaumer M., Czibere L., Turck C.W., Singewald N., Rujescu D., and Frank E. Candidate genes of anxiety-related behavior in HAB/LAB rats and mice: focus on vasopressin and glyoxalase-I. Neurosci Biobehav Rev 31 (2007) 89-102
31. Lenard N.R., and Dunn A.J. Mechanisms and significance of the increased brain uptake of tryptophan. Neurochem Res 30 (2005) 1543-1548
32. Lenczowski M.J., Van Dam A.M., Poole S., Larrick J.W., and Tilders F.J. Role of circulating endotoxin and interleukin-6 in the ACTH and corticosterone response to intraperitoneal LPS. Am J Physiol 273 (1997) R1870-R1877
33. Liebsch G., Montkowski A., Holsboer F., and Landgraf R. Behavioral profiles of two Wistar rat lines selectively bred for high or low anxiety-related behavior. Behav Brain Res 94 (1998) 301-310
34. Maes M., Meltzer H.Y., Bosmans E., Bergmans R., Vandoolaeghe E., Ranjan R., and Desnyder R. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord 34 (1995) 301-309
35. Maes M., Bosmans E., De Jongh R., Kenis G., Vandoolaeghe E., and Neels H. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 9 (1997) 853-858
36. Marques-Deak A.H., Neto F.L., Dominguez W.V., Solis A.C., Kurcgant D., Sato F., Ross J.M., and Prado E.B. Related cytokine profiles in women with different subtypes of major depressive disorder. J Psychiatr Res 41 (2007) 152-159
37. Mathias S., Schiffelholz T., Linthorst A.C.E., Pollmächer T., and Lancel M. Diurnal variations in lipopolysaccharide-induced sleep, sickness behavior and changes in corticosterone levels in the rat. Neuroendocrinology 71 (1999) 375-385
38. Murray I., Sniderman A.D., Havel P.J., and Cianflone K. Acylation stimulating protein (ASP) deficiency alters postprandial and adipose tissue metabolism in male mice. J Biol Chem 274 (1999) 36219-36225
39. Nagata T., Yamada H., Iketani T., and Kiriike N. Relationship between plasma concentrations of cytokines, ratio of CD4 and CD8, lymphocyte proliferative responses, and depressive and anxiety state in bulimia nervosa. J Psychosom Res 60 (2006) 99-103
40. Neumann I.D., Johnstone H.A., Hatzinger M., Liebsch G., Shipston M., Russell J.A., Landgraf R., and Douglas A.J. Attenuated neuroendocrine responses to emotional and physical stressors in pregnant rats involve adenohypophysial changes. J Physiol 508 (1998) 289-300
41. Pomeroy C., Eckert E., Hu S., Eiken B., Mentink M., Crosby R.D., and Chao C.C. Role of interleukin-6 and transforming growth factor-beta in anorexia nervosa. Biol Psychiatry 36 (1994) 836-839
42. Quintanilla R.A., Orellana D.I., Gonzalez-Billault C., and Maccioni R.B. Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway. Exp Cell Res 295 (2004) 245-257
43. Raymond N.C., Dysken M., Bettin K., Eckert E.D., Crow S.J., Markus K., and Pomeroy C. Cytokine production in patients with anorexia nervosa, bulimia nervosa, and obesity. Int J Eat Disord 28 (2000) 293-302
44. Roytblat L., Rachinsky L., Fisher A., Greemberg L., Shapira Y., Douvdevani A., and Gelman S. Raised interleukin-6 levels in obese patients. Obes Res 8 (2000) 673-675
45. Salomé N., Viltart O., Darnaudéry M., Salchner P., Singewald N., Landgraf R., Sequeira H., and Wigger A. Reliability of high and low anxiety-related behaviour: influence of laboratory environment and multifactorial analysis. Behav Brain Res 136 (2002) 227-237
46. Salomé N., Viltart O., Lesage J., Landgraf R., Vieau D., and Laborie C. Altered hypothalamo-pituitary-adrenal and sympatho-adrenomedullary activities in rats bred for high anxiety: central and peripheral correlates. Psychoneuroendocrinology 31 (2006) 724-735
47. Schiepers O.J., Wichers M.C., and Maes M. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 29 (2005) 201-217
48. Shearer W.T., Reuben J.M., Mullington J.M., Price N.J., Lee B.N., Smith E.O., Szuba M.P., Van Dongen H.P., and Dinges D.F. Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight. J Allergy Clin Immunol 107 (2001) 165-170
49. Sluzewska A., Rybakowski J.K., Laciak M., Mackiewicz A., Sobieska M., and Wiktorowicz K. Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann N Y Acad Sci 762 (1995) 474-476
50. Späth-Schwalbe E., Hansen K., Schmidt F., Schrezenmeier H., Marshall L., Burger K., Fehm H.L., and Born J. Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. J Clin Endocrinol Metab 83 (1998) 1573-1579
51. Stouthard J.M., Romijn J.A., Van der Poll T., Endert E., Klein S., Bakker P.J., Veenhof C.H., and Sauerwein H.P. Endocrinologic and metabolic effects of interleukin-6 in humans. Am J Physiol 268 (1995) 813-819
52. Swiergiel A.H., and Dunn A.J. Feeding, exploratory, anxiety- and depression-related behaviors are not altered in interleukin-6-deficient male mice. Behav Brain Res 171 (2006) 94-108
53. Swiergiel A.H., and Dunn A.J. Effects of interleukin-1 β and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field test. Pharmacol Biochem Behav 86 (2007) 651-659
54. Umriukhin A.E., Wigger A., Singewald N., and Landgraf R. Hypothalamic and hippocampal release of serotonin in rats bred for hyper- or hypo-anxiety. Stress 5 (2002) 299-305
55. Vgontzas A.N., Bixler E.O., Papanicolaou D.A., Stratakis C.A., Vela-Bueno A., Gold P.W., and Chrousos G.P. Rapid eye movement sleep correlates with the overall activities of the hypothalamic-pituitary-adrenal axis and sympathetic system in healthy humans. J Clin Endocrinol Metab 82 (1997) 3278-3280
56. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., Lotsikas A., Zachman K., Kales A., Prolo P., Wong M.L., Licinio J., Gold P.W., Hermida R.C., Mastorakos G., and Chrousos G.P. Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endocrinol Metab 84 (1999) 2603-2607
57. Wallenius V., Wallenius K., Ahren B., Rudling M., Carlsten H., Dickson S.L., Ohlsson C., and Jansson J.O. Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 8 (2002) 75-79
58. Wallenius K., Wallenius V., Sunter D., Dickson S.L., and Jansson J.O. Intracerebroventricular interleukin-6 treatment decreases body fat in rats. Biochem Biophys Res Commun 293 (2002) 560-565
59. Wang J., and Dunn A.J. Mouse interleukin-6 stimulates the HPA axis and increases brain tryptophan and serotonin metabolism. Neurochem Int 33 (1998) 143-154
60. Wang J., and Dunn A.J. The role of interleukin-6 in the activation of the hypothalamo-pituitary-adrenocortical axis and brain indoleamines by endotoxin and interleukin-1 beta. Brain Res 815 (1999) 337-348
61. Wernstedt I., Olsson B., Jernas M., Paglialunga S., Carlsson L.M., Smith U., Cianflone K., Wallenius K., and Wallenius V. Increased levels of acylation-stimulating protein in interleukin-6-deficient (IL-6(-/-)) mice. Endocrinology 147 (2006) 2690-2695
62. Xia Z., Sniderman A.D., and Cianflone K. Acylation-stimulating protein (ASP) deficiency induces obesity resistance and increased energy expenditure in ob/ob mice. J Biol Chem 277 (2002) 45874-45879
63. Zalcman S., Murray L., Dyck D.G., Greenberg A.H., and Nance D.M. Interleukin-2 and -6 induce behavioral-activating effects in mice. Brain Res 811 (1998) 111-121
64. Zhang J., Terreni L., De Simoni M.G., and Dunn A.J. Peripheral interleukin-6 administration increases extracellular concentrations of serotonin and the evoked release of serotonin in the rat striatum. Neurochem Int 38 (2001) 303-308